María José Díaz Valentín

Prof. Dr. María José Díaz Valentín

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Nurse Education in Practice
Verified
Journal Article
Closed access
MVMaría José Díaz Valentín
María José Díaz Valentín
MAMargarita Garrido Abejar
Margarita Garrido Abejar
RCRosa María Fuentes Chacón
Rosa María Fuentes Chacón
MPMaría Dolores Serrano Parra
María Dolores Serrano Parra
ELElisa Larrañaga
Elisa Larrañaga
SYSantiago Yubero
Santiago Yubero

1 January 2020 in Medicina de Familia. SEMERGEN
Verified
Journal Article
Closed access
MSM.J. Simón Saiz
M.J. Simón Saiz
RCR.M. Fuentes Chacón
R.M. Fuentes Chacón
MAM. Garrido Abejar
M. Garrido Abejar
SPSerrano Parra
Serrano Parra
MVMaría José Díaz Valentín
María José Díaz Valentín
SYSantiago Yubero
Santiago Yubero

1 June 2017 in Applied Nursing Research
Verified
Journal Article
Closed access
MSMa Dolores Serrano
Ma Dolores Serrano
MGMargarita Garrido
Margarita Garrido
RCRosa María Fuentes Chacón
Rosa María Fuentes Chacón
MSMa José Simón
Ma José Simón
MVMaría José Díaz Valentín
María José Díaz Valentín

7 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
IOIris Otero-Luis
Iris Otero-Luis
ASAlicia Saz-Lara
Alicia Saz-Lara
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
MSMaría José Rodríguez Sánchez
María José Rodríguez Sánchez
MVMaría José Díaz Valentín
María José Díaz Valentín
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Background/Objectives: Heart failure with preserved ejection fraction (HFpEF) has increased in prevalence as the population ages and associated comorbidities increase. Remote ischemic preconditioning (RIPC) has been shown to provide protection against ischemic injury to the heart and other organs. Therefore, the aim of this project will be to analyse the effectiveness of RIPC in terms of arterial stiffness, endothelial function, diastolic function, and exercise capacity in patients with HFpEF. Methods: The PIRIC-FEp study will be a parallel, randomised controlled trial with two groups conducted at the Faculty of Nursing in Cuenca, University of Castilla-La Mancha. Individuals who are diagnosed with HFpEF and are older than 40 years, with a left ventricular ejection fraction ≥50% and a sedentary lifestyle, will be included. The exclusion criteria will include, among others, patients with noncardiac causes of heart failure symptoms, significant pulmonary disease, diabetes, peripheral vascular disease, or myocardial infarction within the previous three months. A sample size of 48 patients was estimated, with 24 for each group. Participants will be randomly allocated (1:1) to either the RIPC intervention group or the control group to evaluate the effects on arterial stiffness, endothelial function, diastolic function, and exercise capacity. Assessments will be conducted at baseline and after a three-month follow-up period. Results: The findings will be published in a peer-reviewed journal article. Conclusions: This study is important for daily clinical practice because it provides a new approach for the treatment of HFpEF patients via RIPC.